DK0674515T3 - Anvendelse af carbostyrilderivater til fremstilling af et medikament til inhibering af interleukin-8 - Google Patents

Anvendelse af carbostyrilderivater til fremstilling af et medikament til inhibering af interleukin-8

Info

Publication number
DK0674515T3
DK0674515T3 DK94929670T DK94929670T DK0674515T3 DK 0674515 T3 DK0674515 T3 DK 0674515T3 DK 94929670 T DK94929670 T DK 94929670T DK 94929670 T DK94929670 T DK 94929670T DK 0674515 T3 DK0674515 T3 DK 0674515T3
Authority
DK
Denmark
Prior art keywords
interleukin
pct
inhibiting
inhibition
drug
Prior art date
Application number
DK94929670T
Other languages
Danish (da)
English (en)
Inventor
Takahide Matsuda
Shigeru Owada
Hiroshi Muta
Miki Aihara
Hisao Takizawa
Ken-Ichi Imagawa
Mikio Kikuchi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK0674515T3 publication Critical patent/DK0674515T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
DK94929670T 1993-10-21 1994-10-17 Anvendelse af carbostyrilderivater til fremstilling af et medikament til inhibering af interleukin-8 DK0674515T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP26341793 1993-10-21
JP26341993 1993-10-21
JP26341893 1993-10-21
JP8964194 1994-04-27
PCT/JP1994/001739 WO1995011026A1 (en) 1993-10-21 1994-10-17 Carbostyril derivative for inhibiting production of interleukin-8

Publications (1)

Publication Number Publication Date
DK0674515T3 true DK0674515T3 (da) 1999-12-20

Family

ID=27467652

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94929670T DK0674515T3 (da) 1993-10-21 1994-10-17 Anvendelse af carbostyrilderivater til fremstilling af et medikament til inhibering af interleukin-8

Country Status (14)

Country Link
US (1) US5637597A (ja)
EP (1) EP0674515B1 (ja)
JP (1) JP2839847B2 (ja)
KR (1) KR100191191B1 (ja)
CN (1) CN1073418C (ja)
AT (1) ATE184793T1 (ja)
AU (1) AU683697B2 (ja)
CA (1) CA2150546C (ja)
DE (1) DE69420832T2 (ja)
DK (1) DK0674515T3 (ja)
ES (1) ES2138092T3 (ja)
GR (1) GR3032091T3 (ja)
TW (1) TW296983B (ja)
WO (1) WO1995011026A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR004214A1 (es) * 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
DE10029404B4 (de) * 2000-06-15 2009-10-29 Jagotec Ag Arzneiformulierung enthaltend Ciclosporin und deren Verwendung
FR2812548B1 (fr) * 2000-08-01 2002-09-20 Sanofi Synthelabo Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale
US7408078B2 (en) * 2002-10-08 2008-08-05 Wyeth Anthranilic acid derivatives useful in treating infection with hepatitis C virus
ATE373502T1 (de) * 2003-07-30 2007-10-15 Otsuka Pharma Co Ltd Carbostyril-derivative zur beschleunigten speichelabsonderung
TWI340650B (en) * 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
MY149159A (en) 2005-11-15 2013-07-31 Hoffmann La Roche Method for treating joint damage
MY157582A (en) * 2007-08-10 2016-06-30 Otsuka Pharma Co Ltd Medical composition containing rebamipipe
KR101104634B1 (ko) * 2009-08-25 2012-01-12 한림제약(주) 레바미피드를 포함하는 류마티스 관절염 예방 또는 치료용 약학 조성물
KR101182114B1 (ko) * 2010-03-05 2012-09-12 한림제약(주) 유효성분으로서 레바미피드를 함유하는 골관절염 예방 또는 치료용 약학 조성물
WO2012114317A1 (en) 2011-02-25 2012-08-30 Nuformix Limited Novel rebamipide complexes and cocrystals
AR085527A1 (es) 2011-03-24 2013-10-09 Otsuka Pharma Co Ltd Una composicon farmaceutica para tratar una enfermedad en la cavidad oral que comprende rebamipida
JP6294773B2 (ja) * 2014-06-27 2018-03-14 株式会社ナールスコーポレーション 口腔粘膜疾患の予防または治療用経口製剤
WO2022128054A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammatory conditions of human skin (iv)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
JPS63119467A (ja) * 1987-10-21 1988-05-24 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体
JPH02178227A (ja) * 1988-12-28 1990-07-11 Otsuka Pharmaceut Co Ltd 腎炎治療剤
JP2812998B2 (ja) * 1989-08-14 1998-10-22 大塚製薬 株式会社 胃炎治療剤
DK0543018T3 (da) * 1991-06-07 1996-02-05 Otsuka Pharma Co Ltd Antidiabetikum
DK0552373T3 (da) * 1991-07-03 1999-12-27 Otsuka Pharma Co Ltd Apoptoseregulator
TW227558B (ja) * 1992-05-14 1994-08-01 Otsuka Pharma Co Ltd
JP2872546B2 (ja) * 1992-11-26 1999-03-17 大塚製薬株式会社 腸粘膜障害保護剤
AU5715994A (en) * 1992-12-24 1994-07-19 Otsuka Pharmaceutical Co., Ltd. Psoriasis remedy
CA2134880A1 (en) * 1993-03-02 1994-09-03 Akira Matsumori Graft rejection inhibitor and il-1 production inhibitor

Also Published As

Publication number Publication date
KR100191191B1 (ko) 1999-06-15
DE69420832T2 (de) 2000-01-13
EP0674515A1 (en) 1995-10-04
WO1995011026A1 (en) 1995-04-27
ATE184793T1 (de) 1999-10-15
GR3032091T3 (en) 2000-03-31
EP0674515B1 (en) 1999-09-22
CN1117268A (zh) 1996-02-21
JPH0812578A (ja) 1996-01-16
CN1073418C (zh) 2001-10-24
JP2839847B2 (ja) 1998-12-16
ES2138092T3 (es) 2000-01-01
US5637597A (en) 1997-06-10
CA2150546C (en) 2004-11-09
TW296983B (ja) 1997-02-01
CA2150546A1 (en) 1995-04-27
AU7864194A (en) 1995-05-08
DE69420832D1 (de) 1999-10-28
KR950703957A (ko) 1995-11-17
AU683697B2 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
FR16C1001I1 (fr) "Dérivé de 2-oxo-1-pyrrolidine et ses applications pharmaceutique"
DK0597088T3 (da) Nye imidazolderivater, deres fremstilling og terapeutiske anvendelser
FI943948A (fi) Heterosykliset hiilihappojohdannaiset
DK0674515T3 (da) Anvendelse af carbostyrilderivater til fremstilling af et medikament til inhibering af interleukin-8
ATE202346T1 (de) Benzofuran derivate und ihre verwendung als inhibitoren der knochenresorption
DK0613894T3 (da) N-Heteroaryl-N'-phenylurinstofderivater, fremstilling og anvendelse deraf
ATE316962T1 (de) Pyrimidin-derivate als selective inhibitoren von cox-2
ATE148108T1 (de) Beta,beta-dimethyl-4-piperidinethanamin-derivat als inhibitoren der cholesterin-biosynthese
ES2149777T3 (es) Derivados de triazol que tienen actividad antifungica.
CA2238875A1 (en) Tri-aryl ethane derivatives as pde iv inhibitors
DE69500673D1 (de) Arzneimittel zur therapeutischen und prophylaktischen Behandlung von Krankheiten, die durch Hyperplasie der glatten Muskelzellen bedingt sind
NO306400B1 (no) N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat
DK0966283T3 (da) Farmaceutiske præparater til helbredelse og forebyggelse af sygdomme, som stammer fra beskadigelse af vaskulære endotelceller
EP0272704A3 (en) Use of pyrazole derivatives in the treatment of immunity diseases and nephropathy
ES2121218T3 (es) Fenoxifenilciclopentenilhidroxiureas.
DK0688218T3 (da) Interleukin-1-inhibitor
ATE294780T1 (de) Arylpiperidin- und aryl-1,2,5,6- tetrahydropyridinamid-derivate mit 5ht1a rezeptor aktivität
NO961719D0 (no) 3-aryl-4-alkyl og 4,5-dialkyl-4H-1,2,4-triazoler som er anvendbare som hukommelsesforsterkere
SE9401965D0 (sv) New compounds
EE03488B1 (et) Meetod anhüdroekgoniini estrite valmistamiseks